Phase I-II Study Using Tocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host Disease.
Phase of Trial: Phase I/II
Latest Information Update: 06 Feb 2018
At a glance
- Drugs Tocilizumab (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 17 Feb 2016 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 23 Nov 2011 New trial record